Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2024-000386
Request Summary: Adverse Drug Reactions (ADRs) for MESALAMINE. Report numbers: E2B_07056269, E2B_07059401, E2B_07057286. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_07094496, E2B_07081568. ADR for GAMMAGARD LIQUID. Report number: 001083422. ADRs for Immunoglobulin (human). Report numbers: E2B_07106164, E2B_07075191, E2B_07063985, 001084047.
Disposition: Disclosed in part
Number of pages: 124